Results 101 to 110 of about 453,541 (160)

Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction

open access: yes, 2007
Copyright © 2007 Chinese Medical Journal, All Rights Reserved.BackgroundEsophageal adenocarcinoma is becoming an increasingly important problem. It has been the most rapidly increasing malignancy in western countries in the last decades, and its ...
Watson, D.   +5 more
core   +1 more source

The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction

open access: yes
Background. The incidence of adenocarcinoma of the esophagogastric junction is rapidly increasing and the extent of lymphadenectomy for such tumors remains controversial.
Griffin SM   +4 more
core   +5 more sources

Personalized organ-preserving approach to the treatment of early esophagogastric junction cancer: a case repor

open access: yesСибирский онкологический журнал
Background. Early esophagogastric junction cancer with submucosal invasion (pT1b) has traditionally been an indication for radical esophagectomy due to the risk of lymphatic metastasis.
S. A. Sokolov   +8 more
doaj   +1 more source

Carcinosarcoma of the Esophagogastric Junction

open access: yes, 2008
Carcinosarcoma of the esophagus and the stomach are rare neoplasms characterized by the simultaneous presence of carcinomatous and sarcomatous elements. There is no report in the literature of carcinosarcoma of the esophagogastric junction. We present a
Marcello Dei Poli   +5 more
core   +1 more source

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)

open access: yesBMC Cancer
Background For resectable adenocarcinoma of the esophagogastric junction (AEG), current treatment exploration primarily focuses on perioperative chemotherapy regimens combined with PD-1/PD-L1 inhibitors, but the long-term survival benefits of still ...
Yingyi Li   +5 more
doaj   +1 more source

Outcomes of Microscopic Residual Tumor after Curative-Intent Surgery in Adenocarcinoma of Esophagogastric Junction

open access: yesSiriraj Medical Journal
Objective: Radical surgery is the mainstay treatment for adenocarcinoma of the esophagogastric junction. The presence of microscopic residual tumor tissue after curative-intent surgery is associated with recurrence.
Chawisa Nampoolsuksan   +12 more
doaj  

Siewert type II adenocarcinoma of esophagogastric junction: treatment status

open access: yes, 2019
The incidence of adenocarcinoma of esophagogastric junction (AEG) has been increased continuously in the past decades, especially in western countries. Siewert type II is regard as the true AEG because of its location, however, the treatment for Siewert ...
Zang, Lu, Li, Shu-Chun
core  

Home - About - Disclaimer - Privacy